Regulatory
Hero Innovation receives partial CTO revocation
Distressed micro-cap winding down legacy payment operations while navigating regulatory compliance to secure fresh capital.

Executive Summary
- The British Columbia Securities Commission (BCSC) issued a partial revocation of a failure-to-file cease trade order (FFCTO) originally issued on February 3, 2025.
- The partial revocation specifically authorizes Hero Innovation Group Inc. to proceed with a private placement financing.
- Proceeds from this financing are strictly restricted to compliance-related purposes, namely bringing the company into compliance with continuous disclosure obligations and securing a full revocation of the FFCTO.
- All other restrictions under the original cease trade order remain in effect.
- This follows a May 29, 2026 announcement where new management (CEO Rainer Yu) disclosed winding down the legacy SideKick digital payment platform due to substantial losses, and explicitly stated the company was seeking financing and CTO revocation.
Material Impact
- The partial CTO revocation is a procedural, regulatory step rather than an operational or commercial catalyst.
- It does not indicate a new product launch, contract win, or revenue-generating initiative.
- The authorized capital raise is ring-fenced for compliance and disclosure remediation, meaning it will not fund business development or growth.
- Given the explicit guidance in the May 29 release regarding the pursuit of financing and CTO revocation, this development is fully expected and incremental.
HRO · Price
Company Overview
- Hero Innovation Group Inc. is a micro-cap technology company that previously operated the SideKick digital payment solution and platform.
- The company has officially wound down its legacy payment operations due to substantial financial losses and lack of commercial success.
- Under newly appointed management, the company is pivoting away from its legacy business and actively seeking a new strategic direction.
- The company remains subject to ongoing regulatory scrutiny and compliance obligations.